12:00 AM
 | 
Aug 15, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

TNF-Kinoid: Completed Phase IIa enrollment

Neovacs completed enrollment of 40 patients in the double-blind, placebo-controlled, international Phase IIa TFN-K-003 trial evaluating 90, 180 and 360 µg intramuscular TNF-Kinoid given on days...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >